ACTUATE THERAPEUTICS RECEIVES EMA ORPHAN MEDICINAL PRODUCT DESIGNATION FOR ELRAGLUSIB FOR THE TREATMENT OF PANCREATIC CANCER

Reuters · 01/07 13:00

Please log in to view news